• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsLobe Sciences
    Picture of Lobe Sciences logo

    LOBE — Lobe Sciences Share News

    CA$0.040.000.00%
    ca flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    • Market Cap
      CA$13.34m
    • Enterprise Value
      CA$9.79m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • LOBE Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    LOBE Dividends
    • Brief: Lobe Sciences Announces Creation Of Wholly Owned Subsidiary, Alera Pharma

      16/08/2024 02:16
    • Brief: Lobe Sciences Announces Update

      04/06/2024 22:10
    • Brief: Lobe Sciences Announces Frederick D. Sancilio Ph.D. To Join Board Of Directors

      31/05/2024 12:36
    • Brief: Former Merck Director And Vanderbilt Vice-Chancellor, Dr. Harry Jacobson, To Join Lobe Sciences Board Of Directors

      30/05/2024 12:55
    • Brief: Lobe Sciences Initiates Phase 1 Clinical Trial Of L-130

      27/06/2023 14:12
    • Brief: Lobe Sciences Appoints Baxter Phillips III Chief Operating Officer

      07/06/2023 12:21
    • Brief: Lobe Sciences Announces Data On Combination Therapeutic Candidates In mTBI And PTSD

      28/09/2021 13:14

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.